Kevin Cassady's profile

Kevin Cassady

Principal Investigator

Nationwide Children's Hospital

I'm working on

8 months ago

Oncolytic Virotherapy, Cellular Therapy, Tumor Immunology, Neuro-Oncology

About

Leads translational viroimmunotherapy across brain and pediatric solid tumors. PI on a Phase I oHSV trial, >$12M in collaborative funding, and an international patent filing. Develops HSV-based platforms and CAR T/NK combinations linked to correlative human studies.

Partnering listings

Learn more

Nationwide Children's Hospital

Enhanced tumor antigen response through oncolytic HSV virotherapy

This innovative approach leverages oncolytic HSV for tumor antigen expression to boost T and B cell responses against gliomas. By combining virotherapy with antigen-presenting cell loading, it aims to enhance durable imm...

TechnologyIn developmentUniversity

Kevin Cassady

Principal Investigator

Nationwide Children's Hospital

Work experience

Nationwide Children's Hospital

Principal Investigator

Top industry applications

Not enough data yet.
Results may appear later and can be imperfect.

Open to opportunities in

Not enough data yet.
Results may appear later and can be imperfect.

Last updated Jan 2026